首页> 外文OA文献 >P-012 YI Decisions to Dose Optimize Infliximab Using Pre-adjustment Therapeutic Drug Monitoring Result in Higher Trough Concentrations and Improved Endoscopic Outcomes

【2h】

P-012 YI Decisions to Dose Optimize Infliximab Using Pre-adjustment Therapeutic Drug Monitoring Result in Higher Trough Concentrations and Improved Endoscopic Outcomes

机译：P-012 Yi使用预调整治疗药物监测的剂量优化英夫利昔单抗的决定，较高的槽浓度和改进的内窥镜结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kelly Orlaith; OʼDonnell Sarah; Stempak Joanne; Steinhart Hillary; Silverberg Mark;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease [J] . Kelly Orlaith B., ODonnell Sarah, Stempak Joanne M., Inflammatory bowel diseases . 2017,第7期

机译：治疗药物监测以指导英夫利昔单抗剂量调节与临床决策在活性炎症肠疾病中单独进行的更好的内窥镜结果相关
2. Editorial: infliximab trough cut-off for perianal Crohn's disease - another piece of the therapeutic drug monitoring-guided infliximab dosing puzzle [J] . Mitrev N., Kariyawasam V., Leong R. W. Alimentary pharmacology & therapeutics. . 2017,第9期

机译：社论：腓承蛋白槽为肛周克罗恩病 - 另一种治疗药物监测引导的英夫利昔单抗给药拼图
3. Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration [J] . Ternant David, Passot Christophe, Aubourg Alexandre, Clinical pharmacokinetics . 2018,第9期

机译：使用单一血清槽浓度的基于模型的嗜泻剂治疗药物监测
4. On evaluating the efficiency of similar therapeutic-effect drugs using multi-criteria decision-making approaches selection result [C] . The 40th International Conference on Computers and Industrial Engineering . 2010

机译：使用多标准决策方法选择结果评估相似疗效药物的效率
5. The Efficacy of Therapeutic Drug Monitoring of Rheumatoid Arthritis Patients on Infliximab [D] . Abolhosn, Rania. 2018

机译：类风湿性关节炎患者治疗药物监测对英夫利昔单抗的疗效
6. A147 COMBINING INFLIXIMAB TROUGH LEVELS AND FECAL CALPROTECTIN LEVELS WITH CLINICAL DATA HAS THE POTENTIAL TO GUIDE CLINICAL DECISION-MAKING IN IMPROVING OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB. [O] . A Amin, C Prosser, K I Kroeker, 2018

机译：A147将英夫利昔单抗低谷水平和粪钙钙蛋白水平与临床数据相结合有可能指导临床决策以改善炎症性肠病患者在维持英菲利布方面的效果。
7. Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease [O] . Orlaith B. Kelly, Sarah Oʼ Donnell, Joanne M. Stempak, 2017

机译：治疗药物监测以指导英夫利昔单抗剂量调节与单独在活性炎症性肠病中单独进行的临床决策具有更好的内窥镜结果相关

P-012 YI Decisions to Dose Optimize Infliximab Using Pre-adjustment Therapeutic Drug Monitoring Result in Higher Trough Concentrations and Improved Endoscopic Outcomes

著录项

引文网络

相似文献

相关主题

期刊订阅